Phase 4
N=122
Fascia Iliaca Blocks for Pain Control After Total Hip Arthroplasty
Arthritis of Hip
Bottom Line
View on ClinicalTrials.gov: NCT03375112 ↗Enrolled (actual)
122
Serious AEs
0.0%
Results posted
Oct 2023
Primary outcome: Primary: Averaged Pain Score — 3.75; 4.11 score on a scale
Study Design & Population
- Study type
- Interventional
- Phase
- Phase 4
- Interventions
- Fascia iliaca compartment block (Procedure); Placebo (Drug); Bupivacaine (Drug)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Henry Ford Health System
- Primary completion
- Oct 2019
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Averaged Pain Score |
3.75; 4.11 | — |
| PRIMARY Morphine Equivalents Consumed |
75.3; 86.0 | — |
| SECONDARY Walking Distance |
67.1; 68.3 | — |
| SECONDARY Time to Up-and-go |
63.7; 66.3 | — |
| SECONDARY Time to Discharge Readiness |
35.1; 35.2 | — |
Summary
The fascia iliaca compartment block (FICB) is a regional block that anesthetizes the femoral, obturator, and lateral femoral cutaneous nerves around the hip. The purpose of this study is to determine whether FICB can reduce postoperative pain and increase progress with physical therapy after total hip arthroplasty (THA). This randomized, double-blind, clinical trial will randomize patients to receive either a FICB or placebo after THA. The primary outcomes will be pain scores reported by the patient post-operatively.
Eligibility Criteria
Inclusion Criteria
- Patients over the age of 18
- Scheduled for total hip arthroplasty at Henry Ford Hospital
- Epidural anesthesia during surgery
Exclusion Criteria
- Pregnancy
- Known intolerance to local anesthetic or narcotics
- Revision hip surgery
Data sourced from ClinicalTrials.gov (NCT03375112). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.